4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001415889-25-019433
Director sold 1,119 shares at $8.71 ($9,746)
- Director acquired 2,127 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A Director | 2025-07-07 | Option exercise 10b5-1 | +2,127 | $2.35 | $4,998 | 55,911 | D |
| RALLIS CHRIS A Director | 2025-07-07 | Sale 10b5-1 | −1,119 | $8.71 | $9,746 | 54,792 | D |
| Derivatives | |||||||
| RALLIS CHRIS A Director | 2025-07-07 | Option exercise · Common Shares 10b5-1 | −2,127 | $2.35 | $4,998 | 178,406 | D |
| Open-market sales · 1,119 sh · avg $8.71 · $9,746 | |||||||
Loading xslF345X05/form4-07072025_090710.xml…